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ABSTRACT
Early osteoporosis is common among adolescent girls with anorexia nervosa (AN) and may result from premature conversion of red (RM)
to yellow bone marrow. We performed right knee magnetic resonance imaging (MRI) on a 1.0 T extremity scanner in 20 patients and 20
healthy controls, aged 16.2 1.6 years (mean SD). Coronal T1-weighted (T1W) images and T1 maps were generated from T1
relaxometry images. Blinded radiologists visually assessed RM in the distal femoral and proximal tibial metaphyses in T1W images
using a scale of signal intensity from 0 (homogeneous hyperintensity, no RM) to 4 (all dark, complete RM). Subjects with AN exhibited
nearly twofold lower metaphyseal RM scores in both the femur (0.64 versus 1.22, p¼.03) and tibia (0.54 versus 0.96, p¼.08). In
relaxometric measurements of four selected regions (femur and tibia amd epiphysis and metaphysis), subjects with AN showed higher
mean epiphyseal but lower metaphyseal T1. The net AN-control difference between epiphysis and metaphysis was 70ms in the femur
(þ31 versus  35ms, p¼.02) and of smaller magnitude in the tibia. In relaxometry data from the full width of the femur adjacent to the
growth plate, AN subjects showed mean T1 consistently lower than in controls by 30 to 50ms in virtually every part of the sampling
region. These findings suggest that adolescents with AN exhibit premature conversion of hematopoietic to fat cells in the marrow of the
peripheral skeleton potentially owing to adipocyte over osteoblast differentiation in the mesenchymal stem cell pool.  2010 American
Society for Bone and Mineral Research.
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Introduction
A
dolescent girls with anorexia nervosa (AN) are at risk for
irreversible bone loss, early onset of osteoporosis, and an
increased fracture risk compared with healthy adolescents.
(1–6)
The skeletal problems seen may be mechanistically linked to
abnormalities in osteoblast and osteoclast progenitors within
bone marrow.
(7–10) Hormonal abnormalities in affected patients
may mediate adipocyte over osteoblast differentiation in the
mesenchymalstemcellpool,resultinginincreasedbonemarrow
fat and premature conversion to yellow marrow (YM). Examples
includealterationsinthesecretionofestrogen,leptin,insulin-like
growth factor 1 (IGF-1), growth hormone, and cortisol in
response to weight loss that may mediate these changes.
(11)
Previous reports examining bone marrow composition in
adolescents with AN have yielded varying results.
(12–19)
Destructive morphologic changes and an alteration in bone
marrow adipocytes have been observed, findings thought to be
a direct result of severe weight loss in affected young women.
(12)
Two reports of magnetic resonance imaging (MRI) evaluations of
bone marrow in these patients have shown a correlation
between hematologic abnormalities, such as anemia and
leukopenia, each a common finding in this patient group, and
severe depletion of total-body fat mass.
(15,17) These studies
suggestthatbonemarrowactivityalternatesbetweenosteoblast
and adipocyte formation, potentially linking increased marrow
adiposity with bone loss and osteoporosis.
(10,20–23) MRI,
computed tomography (CT), and bone marrow biopsy have
been used previously to document hypoplasia of red hemato-
poietic marrow, reduced cellularity, and increased levels of YM in
patients with AN in varying locations, including the lumbar
vertebrae, pelvis, and femoral marrow spaces.
(12–19) Similar lipid
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298accumulation has been observed in aging individuals (ages 52 to
92 years) who suffer from osteoporosis.
(24–30) Other studies
examining marrow changes in young women with AN have
shown an accumulation of extracellular hyaluronic acid in
marrow spaces, a reduction of both YM and RM, and increased
free water content.
(13,15) This hyperhydration and a reduced
bone marrow fat fraction, observed via spectroscopy and
relaxometry techniques, is suspected to be a physiologic
response to reduced hematopoietic requirements as a result
of decreased body mass.
(13–14,17,31) As girls achieve peak bone
mass during adolescence, disease-associated alterations in
bone marrow composition and a subsequent inhibition of bone
formation during this important developmental period may
contribute to the increased fracture risk seen in these patients.
To our knowledge, bone marrow adiposity has not been
investigated previously using MRI in adolescents with AN. This
study aimed to investigate bone marrow composition in this
young patient group and specifically to analyze the distribution
of hemopoietic red marrow (RM) and fatty YM. We sought to
understand the role of bone marrow in the impaired bone
turnover and skeletal sequelae seen in adolescent girls with AN.
Materials and Methods
Subjects
Human subjects approval was obtained from the Committee on
Clinical Investigation at Children’s Hospital Boston. All partici-
pants provided written informed consent; for those under 18
years of age, a parent or guardian also provided consent. Female
volunteers, ages 13 to 18 years (mean 16.3 years), were recruited
prospectively from the adolescent outpatient clinic at Children’s
HospitalBoston.EachpatientmetdiagnosticcriteriaforANusing
the Diagnostic and Statistical Manual of Mental Disorders, Fourth
Edition (DSM-IV). The patients had body mass indexes (BMIs)
between 14.4 and 20.5kg/cm
2, had secondary amenorrhea of at
least 3 months’ duration, had no history of illness affecting bone
metabolism, and had received no glucocorticoid therapy or
other hormonal treatment within the past 3 months. Twenty
healthy controls were obtained through the Children’s Hospital
Boston outpatient adolescent program or a Craigslist.com
posting. These patients similarly had no history of illness
affecting bone metabolism and had received no glucocorticoid
therapy or hormonal treatment within the past 3 months. The
controls had BMIs between 18.8 and 25.5kg/m
2. Adolescents
with AN were matched with controls of the same race and
pubertal stage who were within 2 years of the patient’s
chronologic age.
Procedure
Weight and height data were obtained using a single calibrated
scale (Tronix, Carol Steam, IL, USA) and stadiometer (Detecto,
Webb City, MO, USA). BMI was calculated as weight in kilograms
divided by the square of height in meters. An human chorionic
gonadotropin (hCG) pregnancy test (SA Scientific, Ltd., San
Antonio, TX, USA) was performed after consent had been
obtained. A semistructured interview was conducted to obtain
information about each patient’s medical and bone fracture
history, daily dietary intake, and level of physical activity. For
patients with AN, severity of illness was assessed using self-
reported information on duration of disease, if and how many
timesshehadbeenhospitalizedforAN(medicalandpsychiatric),
and the date and numbers of her lowest and highest weights.
MRI
All subjects underwent MRI of the right knee in a 1 T extremity
unit (ONI Medical Systems, Wilmington, MA, USA). Coronal T1-
weighted (T1W) spin-echo images (TR 400ms, TE 15ms, 4mm
slice thickness, 5mm gap) were obtained through the knee with
afieldofviewof16cmtoincludethedistalfemoralandproximal
tibial metaphyses. Additionally, we performed a spin-lattice
relaxation (T1) relaxometry acquisition consisting of seven fast-
spin-echo (FSE) acquisitions of varying TR values (TR 350–
3000ms, TE 17ms, 5mm slice thickness, 2mm gap) through the
knee. Reproducibility (expressed as percent coefficient of
variation) for T1 measurements with this scanner using standard
phantoms is 2% to 4%.
Visual assessment
Two blinded pediatric radiologists visually assessed all the
images for RM content, designated as areas of low signal
intensity. Each of the distal femoral and proximal tibial
metaphyses was graded according to the following unique
scale developed specifically for this study: 0¼homogeneous
hyperintensity, no RM; 1¼few hypointense signal areas, mild
RM; 2¼scattered hypointense areas, moderate RM; 3¼more
diffuse hypointense regions, extensive RM;4¼all dark,complete
RM. Scores were decided by consensus (Fig. 1).
Relaxometry assessment
T1 maps from the T1 relaxometry images were generated using a
two-parameter-fit iterative algorithm (based on the assumption
of monoexponential T1 relaxation processes) developed in-
house using IDL software (ITT Visual Information Systems,
Boulder, CO, USA).
On initial visual inspection of the T1W spin-echo images, the
control subjects revealed a consistent pattern of lower signal
intensity (red arrows in Fig. 1A, B)—presumed to be residual
RM—within the medial aspect of the distal femoral metaphysis
and the central aspect of the proximal tibial metaphysis, in
accordance with previously reported studies.
(32) Adolescents
with AN showed higher T1 signal intensity in these same
anatomic locations (see Fig. 1C, D). The epiphyses, both femoral
and tibial, showed uniformly high signal intensity in all subjects,
presumed to be YM (yellow arrows in Fig. 1A, B). Based on these
observations, four regions of interest were selected—one each
in the medial distal femoral metaphysis, the central proximal
tibial metaphysis, and the distal femoral and proximal tibial
epiphyses. Mean T1 values for each region were recorded (Image
J, NIH, Bethesda, MD, USA) (see Fig. 1). The anatomic locations of
these regions were consistent for all subjects, and all regions of
interest were consistently 72 square pixels (approximately
25mm
2) in size.
Finally, based on trends seen inthe analysis of the four regions
of interest described above, T1 values were recorded for a larger
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50 10mm in size) for both the AN subjects and controls
spanning the full width of the distal femoral metaphysis just
above the growth plate, adjacent to the growth plate, and over
two consecutive slices (shown in Fig. 1C, middle slice, and Fig. 1D,
next more anterior slice). To eliminate spurious readings (usually
caused by patient motion or magnetic field inhomogeneity), T1
values below 200ms or greater than 1000ms (2% of the data)
were discarded.
Statistical analysis
Characteristics of the two samples were compared by Fisher
exact test for dichotomous and polytomous variables, Wilcoxon
rank-sum test for highly skewed measures, and Student’s t test
for other continuous measures. The visual assessments of signal
intensity were compared between AN and control by analysis of
covariance, adjusting for age. Because these data were mildly
skewed, the results were corroborated by Wilcoxon test.
The four-region sample of relaxometric data was analyzed by
mixed-model analysis of variance (ANOVA). Mean T1 was
calculated in each subject’s four regions of interest and analyzed
separately for femur and tibia. The independent variables were
age, AN status, and location (metaphysis or epiphysis), with
random effects accounting for correlation within matched pair
and subject. A location AN interaction term was included to
testwhethertheeffectofANstatusdifferedbetweenmetaphysis
and epiphysis.
The full-width femur data were analyzed similarly, with
individual voxel T1 as dependent variable. Location within the
rectangular sampling region was characterized by a seven-
segment division extending from medial to lateral (see Fig. 1C)
and a two-segment division from superior to inferior (see
Fig. 1D). Independent variables in the ANOVA were age, AN
status, MRI slice, sampling segment location, and all interactions
among AN, slice, and segment. Random effects were included to
account for correlation with matched pair and subject.
In both relaxometric analyses, contrasts of interest and age-
adjusted means for each combination of independent variables
were constructed from the ANOVA model with standard errors
for assessment of statistical significance. A two-tailed p value of
less than .05 wasconsidered statistically significant. SAS software
(Version 9.1, Cary, NC, USA) was used for all computations.
Results
Clinical characteristics
Basic demographic and clinical data collected from all subjects
are shown in Table 1. Compared with control subjects, the
participantswithANhadsimilarageandheightbutlowerweight
and BMI. There were no differences between the patients with
AN and controls with respect to race, ethnicity, and self-reported
fracture history or family history of osteoporosis. There were no
significant trends noted in the location of fractures between the
two groups. One pathologic fracture was reported: a vertebral
compression fracture in a subject with AN. None of the
participants had sustained a fracture within 6 months of study
participation.
Visual assessment of MRI results
Among the 39 subjects with acceptable image quality for visual
assessment, adolescents with AN exhibited lower scores than
controls (higher T1 signal intensity, less RM) in the distal femoral,
as well as proximal tibial metaphyses (Table 2). The age-adjusted
difference in mean score was nearly twofold at the femur (0.64
versus 1.22, p¼.03) as well as the tibia (0.54 versus 0.96, p¼.08).
Visual assessment of the T1W spin-echo images also
consistently identified residual RM within the medial aspect of
the distal femoral metaphysis and the central aspect of the
proximal tibial metaphysis in all control subjects, and these areas
were further studied using relaxometry data. There was no
relation of duration of either AN or amenorrhea to the visual
assessment measures (p>.10).
MRI relaxometry results
Thirty-six images (18 AN, 18 control) were free of motion or
technical problems and were of sufficient quality for the initial
relaxometry analysis. Mean T1 values were consistently lower in
the epiphyses than in the metaphyses for all subjects (controls
and patients with AN), by 120ms in the femur and 70ms in the
tibia, both highly significant (Table 3). Compared with controls,
Fig. 1. (A,B)T 1-weightedMRIimagesoftherightdistalfemurofacontrol
subject: central slice (A) and one slice anterior (B). (C, D) Corresponding
images from an anorexic subject. Lower-signal-intensity regions of
residual red marrow are much more apparent in the distal femoral
metaphyses of the control subject compared with the homogeneous
high-signal-intensity fatty marrow seen in the patient with AN. In both
groups, T1-weighted signal intensity was evaluated in four regions of
interest: the medial aspect of the distal femoral metaphysis; the central
aspect of the proximal tibial metaphysis, chosen because of striations of
hematopoieticmarrowevidentincontrols(redarrowsinAandB);andthe
distal femoral and proximal tibial epiphyses, where yellow marrow was
more predominant and the signal intensity more homogeneous (yellow
arrows in A and B). The red rectangles in parts (C) and (D) show the
location of the full femoral region of interest. Each rectangle was further
subdivided into seven transverse segments extending from lateral to
medial (L and M in C) and two horizontal segments, superior and inferior
(D) for statistical analysis.
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lower mean T1 in the metaphyses. This pattern occurred in both
thefemurandthetibia(seeFig.1).TheAN-controldifferencewas
not statistically significant in any of the four individual regions
(see Table 3), but the net AN-control difference between
epiphysis and metaphysis was 70ms and significant in the femur
( 35 versus þ31ms, p¼.02) and of smaller, nonsignificant
magnitude but similar pattern in the tibia ( 17 versus þ11ms,
p¼.28). The AN-control difference in the distal femur, though
not statistically significant (p¼.12), was largest in estimated
magnitude of the four regions studied and led us to examine
the T1 relaxometry data from the distal femur in a more
systematic fashion.
Relaxometry data from the full width of the femoral
metaphyses were more revealing. Thirty-two images (18 AN,
14 control) were of sufficient quality for the full-width analysis.
Subjects with AN showed mean T1 consistently lower than in
controls by 30 to 50ms in every part of the sampling region with
the exception of the lattermost aspect of the metaphysis (Fig. 2).
Within the rectangular region of interest, the effect was most
pronounced in the medial and superior areas regardless of slice.
The effect alsowas greaterinthe middle slice comparedwith the
moreanteriorslice.TherewasnorelationofeitherdurationofAN
or amenorrhea to any of the relaxometry measures (p>.10).
Discussion
We found significant differences between bone marrow
composition within the knee in adolescent girls with AN
compared with their healthy counterparts. Both qualitative and
quantitative findings support our hypothesis of premature
conversion of hematopoietic to fatty marrow in adolescent girls
with AN. Blinded visual assessments revealed increased T1 signal
intensity, presumably related to fat content, most pronounced in
the distal femoral metaphyses in girls with AN compared with
their healthy counterparts. Similarly, T1 values obtained at fixed
anatomic locations demonstrated a consistent increase in YM
content in the metaphyses of affected patients. These results
suggest that young women with this disease experience a
striking premature conversion of RM to YM during a develop-
mental period when they should exhibit a more heterogeneous
marrow cellularity. Noteworthy is the fact that the bone marrow
findings in the participants with AN persisted after accounting
for both duration of amenorrhea and disease.
Thefinding of increased YMamong the adolescents with AN is
concerning, with potential implications for fracture risk in these
patients. There are several explanations as to why increased YM
within bone marrow may increase fracture risk. As proposed by
Gimble
(10) and Okazaki,
(33) the process of adipogenesis may
compete with osteogenesis, resulting in the differentiation of
mesenchymal stem cells into adipocytes over osteoblasts. This
may be due to altered hormonal levels, including low leptin and
IGF-1 and elevated cortisol.
(11) However, other investigators
suggest alternate pathways by which increased marrow fat may
predispose to bone fragility. Bone fat can contribute to
diminished structural bone integrity, resulting in diminished
bone mass and therefore reduced skeletal strength.
(34) Addi-
tionally, the quality of bone marrow itself may be a determinant
of mechanical vertebral strength. Therefore, it has been
suggested that the presence of fat may reduce the biomecha-
nical strength of bone. Marrow-filled intertrabecular spaces
function as ‘‘energy dampers’’ and serve as biomechanical
support structures for medullary bone. While RM contributes to
hydrostatic strengthening, YM, which is higher in fat content and








Age, years 16.1 1.6 16.3 1.6 .72
Height, cm 164.0 6.5 163.9 5.8 .98
Weight, kg 45.5 4.5 60.0 6.6 <.0001
BMI, kg/m
2 16.9 1.5 22.3 2.0 <.0001
N (%)
Race 1
Caucasian 18 (90) 17 (85)
Asian 2 (10) 2 (10)
Other 0 (0) 1 (5)
Ethnicity 1
Hispanic 1 (5) 0 (0)
Non-Hispanic 19 (95) 20 (100)
Fracture history .53
Yes 12 (60) 9 (45)
No 8 (40) 11 (55)
Family history of osteoporosis .13
Yes 8 (40) 2 (10)
No 10 (50) 15 (75)
Don’t know 2 (10) 3 (15)
Median
(minimum–maximum)
Past fractures 1 (0–3) 0 (0–4) .48
Duration of anorexia, months 12 (2–108) —
Duration of amenorrhea 8 (3–99) —
aFrom Student’s t test comparing means, Fisher exact test comparing
percentages,orWilcoxontestcomparingmedians.p¼1isavalidou tcome
for Fisher exact test, indicating maximal nonsignificance. Similar results
were obtained from paired (age-matched) or age-adjusted analysis.
Table 2. Visual Assessment of T1 Signal Intensity at Standard





b Anorexic (20) Control (19)
Distal femur metaphysis 0.64 0.18 1.22 0.18 .03
Proximal tibia metaphysis 0.54 0.16 0.96 0.16 .08
aAge-adjusted mean standard error, scale from 0 (homogeneous
hyperintensity, characteristic of yellow marrow) to 4 (all dark, character-
istic of red marrow). One control image was of insufficient quality to
assess;
bFrom analysis of covariance comparing anorexic to control, adjusted
for age. Corroborated by Wilcoxon test allowing for skewed data.
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thereby conferring an increased fracture risk.
(32)
As exhibited by elderly women who experience increased
marrow adipogenesis following menopause, estrogen appears
to be an adipogenesis inhibitor.
(10,33) Estrogen and leptin have
beensuggestedasthelinksbetweenfatandbone,bothofwhich
are low in AN, potentially moderating an inverse relationship
between mesenchymal stem cell (MSC) differentiation into
osteoblasts and adipocytes. High-affinity leptin receptors are
present in human mesenchymal stem cells derived from healthy
controlandosteoporotic donors.
(8) Therefore,hormonalchanges
that ensue in a young women with AN may cause such
individuals to experience a ‘‘switch’’ from osteogenesis to
adipogenesis, resulting in more lipid accumulation in the bone
marrow compared with a healthy adolescent. Mesenchymal
stem cells that express the ligand-activated transcription factor
peroxisome proliferator–activated receptor l2 (PPARl2), when
activated, are likely to commit into the adipocyte lineage.
(24)
Recent investigations of marrow adiposity and bone mass in
healthy adolescent girls demonstrate an inverse relationship
between marrow adiposity and bone density in both the axial
and appendicular skeleton. This observation supports the
hypothesis that a common progenitor cell exclusively differ-
entiates into either the cell lineage responsible for bone
formation or that responsible for fat formation.
(7)
The finding of increased YM in the bone marrow of adolescent
girls with AN is supported by similar observations in animal
models. Congenic mice with low IGF-1 levels demonstrated
similar physiologic characteristics to humans with AN, with
reduced cortical and trabecular bone mineral density and
impaired bone formation.
(35) Ackert-Bicknell and colleagues
showed that these mice have greater PPARg gene expression, a
positive regulator of adipogenesis, and a suppressor of
osteogenesis.
(36) In a separate study investigating the relation-
ship between BMD and bone marrow composition in humans,
Schellinger and colleagues
(34) reported that although increased
fat fraction in bone marrow correlates with structurally
weakened bones, it does not necessarily equate with lower
BMD. The investigators demonstrated that a majority (73%) of
sample subjects with more fragile bones had a bone marrow fat
fraction above 54%, although this finding was not significantly
correlated with a low BMD. In another model, administration of
growth hormone to hypophysectomized rats inhibited the
differentiation of stromal cells into adipocytes.
(37) These animal
data suggest that the characteristic fall in IGF-1 is an important
signal for adipogenesis in marrow and in AN may stem from
growth hormone resistance, which has been shown to be
present in these young women.
(38) This hormonal alteration also
mayplay apathophysiologic role in the marrow changes that are
seen in adolescents and young women with AN.
Conflicting conclusions regarding bone marrow adiposity in
young women with AN may be due to the fact that different
Fig. 2. SubjectswithANshowedgenerallylowermeanT1values(lessred
marrow)thancontrols.Withineachslice,theeffectwasmostpronounced
in the medial and superior regions. The effect also was greater in the
middle slice than in the more anterior slice. Bars indicate meanþ1 SEM.





b p, AN vs contro All (36) AN (18) Control (18)
Distal femur
Epiphysis, lateral 444 57 460 63 429 48 þ30.9 21.9 .17
Metaphysis, medial 564 107 547 99 582 114  35.1 21.9 .12
p, metaphysis versus epiphysis <.0001 .02
Proximal tibia
Epiphysis, lateral 436 54 441 39 430 67 þ11.2 21.2 .60
Metaphysis, central 507 82 498 87 515 79  17.2 21.2 .42
p, metaphysis versus epiphysis <.0001 .28
aMean standarddeviation.LowvaluesofT1arecharacteristicofyellowmarrow,highvaluescharacteristicofredmarrow.Twoanorexicimagesandtwo
control images were of insufficient quality to assess;
bDifference between anorexic and control means standard error estimated by mixed-model analysis of covariance adjusted for age, location, and
intrasubject correlation.
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marrow, including dual-energy CT,
(16) bone marrow biopsy,
(31)
and magnetic resonance relaxometry, with or without spectro-
scopy.
(15,17,18) In addition, conclusions often have been based on
the qualitative judgment of radiologists, as well as retrospective
chart reviews. In one study, results from dual-energy CT
demonstrated disproportionately increased levels of intraver-
tebral fat in patients with AN for their severity of osteopenia,
whereas individuals with Cushing syndrome demonstrated no
such fat increase.
(16) This early study provided proof of concept
that patients with AN exhibit increased marrow fat, the etiology
of which was not understood. Similarly, Abella and colleagues
performed bone marrow biopsies in adolescents and young
women with AN.
(12) While 20% of patients with AN exhibited
complete gelatinous degeneration of bone marrow, 39% of
patients with AN had hypoplastic or aplastic bone marrow,
consisting of 10% increased marrow fat fraction, compared with
that of healthy individuals. The present study is the first to use
images obtained via noninvasive MRI in order to both
qualitatively and quantitatively assess bone marrow adiposity
in adolescents with AN compared with healthy girls. Novel
information was obtained on conversion of RM to YM, which
represents a normal developmental process and one that
appears to be accelerated in AN.
Limitations of this study must be acknowledged and
considered. Our sample size was relatively small for this
preliminary study. To acquire more conclusive results regarding
quantitative MR assessment of marrow fat, future studies of a
larger sample size areneeded to support these initial results. This
study demonstrates the feasibility of using a 1.0 T extremity
scanner for relaxometry studies in the musculoskeletal system
and, in particular, in girls with AN. Because patients with
psychiatric disorders such as AN often exhibit significant anxiety
andclaustrophobiawhenscannedinconventional,enclosedMRI
scanners, documentation of the capability and reliability of an
extremity scanner is of importance. Avoiding an enclosed
scanner also greatly increased subject recruitment and the
feasibility of this study. Admittedly, a 1.0 T open-magnet
configuration has lower resolution and lower signal-to-noise
ratio than a higher-field-strength whole-body scanner. However,
sufficient resolution and signal-to-noise ratio were achieved via
this approach. Since changes in marrow fat appear to be site-
specific, correlating measurements in the peripheral versus axial
skeleton also will be informative. In contrast to adult studies that
have focused primarily on the axial skeleton, our methodology
afforded an assessment of the peripheral skeleton, which is
highly informative in a pediatric population that is most likely to
experience extremity fractures. Data on fracture history, an
endpoint of potential clinical importance, was obtained by self-
report with inherent limitations, especially in an adolescent
patient group. We did not obtain information on menarchal age
in the patients or healthy controls. This point should be
examined in future studies because some of the differences
observed may have been affected by differences in skeletal
maturity. With a 1 T scanner, we also were limited in our ability to
evaluate cortical thickness and bone size. An important question
to address in future studies is whether parameters of bone size
are related to marrow composition. Lastly, we did not have bone
density or laboratory data to correlate with our imaging findings.
Therefore, explanations for the marrow findings are speculative
at this point in the absence of hormonal measurements, which
will be important to obtain in future protocols.
In summary, it has been documented that girls suffering from
AN experience early bone loss, resulting in heightened risk for
bone fracture and early osteoporosis. We observed a higher fatty
marrow content within the metaphyses of the distal femur and
proximal tibia in adolescent girls with AN compared with healthy
age- and race-matched control subjects. These MRI findings
suggest premature conversation of RM to YM in adolescents
suffering from this eating disorder. Given the known hormonal
abnormalities in affected individuals, these changes may
accelerate adipocyte conversion over osteoblast differentiation
in the mesenchymal stem cell pool, resulting in increased bone
marrow adipogenesis and premature conversion to YM. These
marrow findings are important clinically because they may
mediate, in part, the early osteoporosis and heightened fracture
risk seen in these young patients.
Disclosures
The authors state that they have no conflicts of interest.
Acknowledgments
We wish to acknowledge and thank the adolescents and their
families for their participation in this study. This project was
supported by National Institutes of Health (NIH) Grant R01
HD043869 (CMG) and by the Children’s Hospital Radiology
Foundation, Inc.
References
1. Gordon CM, Goodman E, Emans SJ, et al. Physiologic regulators of
bone turnover in young women with anorexia nervosa. J Pediatr.
2002;141:64–70.
2. Soyka LA, Grinspoon S, Levitsky L, Herzog DB, Klibanski A. The effects
ofanorexianervosaonbonemetabolisminfemaleadolescents.JClin
Endocrinol Metab. 1999;84:4489–4496.
3. Bachrach LK, Guido D, Katzman D, Litt IF, Marcus R. Decreased bone
density in adolescent girls with anorexia nervosa. Pediatrics 1990;
86:440–447.
4. Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR. The clinical
course of osteoporosis in anorexia nervosa. JAMA. 1991;265:1133–
1138.
5. Golden NH. Eating disorders in adolescence: what is the role of
hormone replacement therapy? Curr Opin Obstet Gynecol. 2007;
19:434–439.
6. Misra M. Long-term skeletal effects of eating disorders with onset
during adolescence. Ann NY Acad Sci. 2008;1135:212–218.
7. Di Iorgi N, Rosol M, Mittelman SD, Gilsanz V. Reciprocal relation
between marrow adiposity and the amount of bone in the axial and
appendicular skeleton of young adults. J Clin Endocrinol Metab.
2008;93:2281–2286.
8. Hess R, Pino A, Rios S, Fernandez M, Rodriguez J. High- affinity leptin
receptors are present in human mesenchymal stem cells (MSCs)
derived from control and osteoporotic donors. J Cell Biochem.
2004;94:50–57.
BONE MARROW CHANGES IN ANOREXIA NERVOSA Journal of Bone and Mineral Research 3039. Gimble JM, Nuttall ME. Bone and fat: old questions, new insights.
Endocrine. 2004;23:183–188.
10. Gimble JM, Zvonic S, Floyd E, Kassem M, Nuttall M. Playing with bone
and fat. J Cell Biochem. 2006;98:251–266.
11. Shapses SA, Riedt CS. Bone, body weight and weight reduction: what
are the concerns? J Nutr. 2006;136:1453–1456.
12. Abella E, Feliu E, Granada I, et al. Bone marrow changes in anorexia
nervosa are correlated with the amount of weight loss and not with
other clinical findings. Am J Clin Pathol. 2002;118:582–588.
13. Vande Berg BC, Malghem J, Devuyst O, Maldague B, Lambert
MJ. Anorexia nervosa: correlation between MR appearance of
bone marrow and severity of disease. Radiology 1994;193:859–
864.
14. Vande Berg BC, Malghem J, Lecouvet FE, Lambert M, Maldague BE.
Distributionofserouslikebonemarrowchangesinthelowerlimbsof
patients with anorexia nervosa: predominant involvement of the
distal extremities. AJR. 1996;166:621–625.
15. Geiser F, Mu ¨rtz P, Lutterbey G, et al. Magnetic resonance spectro-
scopic and relaxometric determination of bone marrow changes in
anorexia nervosa. Psychosom Med. 2001;63:631–637.
16. Mayo-Smith W, Rosenthal DI, Goodsitt MM, Klibanki A. Intravertebral
fat measurement with quantitative CT in patients with Cushing
disease and anorexia nervosa. Radiology 1989;170:835–838.
17. Okamoto K, Ito J, Ishikawa K, Sakai K, Tokiguchi S. Change in signal
intensity on MRI of fat in the head of markedly emaciated patients.
Neuroradiology 2001;43:134–138.
18. Demaerel P, Daele MCV, De Vuysere S, Wilms G, Baert AL. Orbital fat
edemain anorexia nervosa:a reversible finding.AJNR. 1996;17:1782–
1784.
19. Bredella MA, Fazeli PK, Miller KK, et al. Increased bone marrow fat in
anorexia nervosa. J Clin Endocrinol Metab. 2009;94:2129–2136.
20. Custer RP, Ahfeldt FE. Studies on the structure and function of bone
marrow: II. Variations in cellularity in various bones with advancing
years of life and their relative response to stimuli. J Lab Clin Med.
1932;17:960–962.
21. Vost A. Osteoporosis: a necropsy study of vertebrae and iliac crests.
Am J Pathol. 1963;43:143–151.
22. Hartsock RJ, Smith EB, Petty CS. Normal variations with aging of the
amount of hematopoietic tissue in bone marrow from the anterior
iliac crest: a study made from 177 cases of sudden death examined
by necropsy. Am J Clin Pathol. 1965;143:326–331.
23. Meunier P, Aaron J, Edouard C, Vignon G. Osteoporosis and the
replacement of cell populations of the marrow by adipose tissue: a
quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res.
1971;80:147–154.
24. Duque G. Will reducing adipogenesis in bone increase bone mass?
PPARg2 as a key target in the treatment of age-related bone loss.
Drug News Perspect. 2003;16:341–346.
25. Lang P, Steiger P, Faulkner K, Gluer C, Genanth K. Osteoporosis:
current techniques and recent development in quantitative bone
densitometry. Radiol Clin North Am. 1991;29:49–76.
26. Dooms GC, Fisher MR. Bone marrow imaging: magnetic resonance
studies related to age and sex. Radiology 1985;155:429–432.
27. Demmler K, Burkhardt R. Relations between fatty tissue, cancellous
bone and vascular pattern of the iliac bone in aplastic anaemia. Bibl
Haematol. 1978;45:109–117.
28. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T,
Kassem M. Adipocyte tissue volume in bone marrow is increased
with aging and in patients with osteoporosis. Biogerontology
2001;2:165–171.
29. Kaarian L, Graves G. Compressive strength characteristics of the
human vertebral column. Spine. 1977;2:1–14.
30. Nuttall ME, Gimbel JM. Is there a therapeutic opportunity to either
prevent or treat osteopenic disorders by inhibiting marrow adipo-
genesis? Bone. 2000;27:177–184.
31. Devuyst O, Lambert M, Rodhain J, Lefebvre C, Coche E. Haematolo-
gical changes and infectious complications in anorexia nervosa: a
case-control study. Q J Med. 1993;86:791–799.
32. Moore SG, Dawson KL. Red and yellow marrow in the femur: age-
related changes in appearance at MR Imaging. Radiology
1990;175:219–223.
33. Okazaki R, Inoue D, Shibata M, et al. Estrogen promotes osteoblast
differentiation and inhibits adipocyte differentiation in mouse bone
marrowstromalcelllinesthatexpressestrogenreceptor(ER)alphaor
beta. Endocrinology 2002;143:2349–2356.
34. Schellinger D, Lin CS, Lim J, Hatipoglu HG, Pezzullo JC, Singer AJ.
Bone marrow fat and bone mineral density on proton MR spectro-
scopy and dual-energy X-ray absorptiometry: their ratio as a new
indicator of bone weakening. AJR. 2004;183:1761–1765.
35. Rosen CJ, Ackert-Bicknell CL, Adamo ML, et al. Congenic mice with
low serum IGF-I have increased body fat, reduced bone mineral
density, and an altered osteoblast differentiation program. Bone.
2004;35:1046–1058.
36. Ackert-Bicknell CL, Demissie S, Marı ´n de Evsikova C, et al. PPARg by
dietary fat interaction influences bone mass in mice and humans.
J Bone Miner Res. 2008;23:1398–1408.
37. Appiagyei-Dankah Y, Tapiador CD, Evans JF, Castro-Magana M, Aloia
JF, Yeh JK. Influence of growth hormone on bone marrow adipogen-
esis in hypophysectomized rats. Am J Physiol Endocrinol Metab.
2003;284:E566–E573.
38. Misra M, Miller KK, Bjornson J, et al. Alterations in growth hormone
secretory dynamics in adolescent girls with anorexia nervosa. J Clin
Endocrinol Metab. 2003;88:5615–5623.
39. Michaelsson K, Bergstrom R, Mallmin H, Holmberg L, Wolk A, Ljun-
ghallS.Screeningforosteopeniaandosteoporosis:selectionbybody
composition. Osteoporos Int. 1996;6:120–126.
304 Journal of Bone and Mineral Research ECKLUND ET AL.